PROFOUND MEDICAL CORP. Operating Lease Cost
PROFOUND MEDICAL CORP. (PROF) reported Operating Lease Cost of $118.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- PROFOUND MEDICAL CORP. operating lease, cost for the quarter ending 2026-06-30 was $118.00K, a 103.45% increase year-over-year.
- PROFOUND MEDICAL CORP. operating lease, cost for the quarter ending 2026-03-31 was $119.00K, a 105.17% increase year-over-year.
- PROFOUND MEDICAL CORP. operating lease, cost for the quarter ending 2025-06-30 was $58.00K.
- PROFOUND MEDICAL CORP. operating lease, cost for the quarter ending 2025-03-31 was $58.00K.
- PROFOUND MEDICAL CORP. operating lease, cost for fiscal 2025 was $238.00K, a 2.06% decline from fiscal 2024.
- PROFOUND MEDICAL CORP. operating lease, cost for fiscal 2024 was $243.00K, a 1.62% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. operating lease, cost for fiscal 2023 was $247.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 12 month |
|---|---|---|---|
| 2026-06-30 | $118.00K 10-Q · filed 2026-08-06 | $237.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $119.00K 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $238.00K 10-K · filed 2026-03-05 | ||
| 2025-06-30 | $58.00K 10-Q · filed 2026-08-06 | $116.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $58.00K 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $243.00K 10-K · filed 2026-03-05 | ||
| 2023-12-31 | $247.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |